CVS Health Basic EPS 2010-2025 | CVS
CVS Health annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- CVS Health basic eps for the quarter ending June 30, 2025 was $0.81, a 42.55% decline year-over-year.
- CVS Health basic eps for the twelve months ending June 30, 2025 was $3.60, a 36.17% decline year-over-year.
- CVS Health annual basic eps for 2024 was $0.004B, a 43.45% decline from 2023.
- CVS Health annual basic eps for 2023 was $0.006B, a 97.26% increase from 2022.
- CVS Health annual basic eps for 2022 was $0.003B, a 45.8% decline from 2021.
| CVS Health Annual Basic EPS | |
|---|---|
| 2024 | $3.67 |
| 2023 | $6.49 |
| 2022 | $3.29 |
| 2021 | $6.07 |
| 2020 | $5.48 |
| 2019 | $5.10 |
| 2018 | $-0.57 |
| 2017 | $6.47 |
| 2016 | $4.93 |
| 2015 | $4.66 |
| 2014 | $3.98 |
| 2013 | $3.77 |
| 2012 | $3.04 |
| 2011 | $2.59 |
| 2010 | $2.51 |
| 2009 | $2.58 |
| CVS Health Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $0.81 |
| 2025-03-31 | $1.41 |
| 2024-12-31 | $1.31 |
| 2024-09-30 | $0.07 |
| 2024-06-30 | $1.41 |
| 2024-03-31 | $0.88 |
| 2023-12-31 | $1.59 |
| 2023-09-30 | $1.76 |
| 2023-06-30 | $1.48 |
| 2023-03-31 | $1.66 |
| 2022-12-31 | $1.78 |
| 2022-09-30 | $-2.59 |
| 2022-06-30 | $2.31 |
| 2022-03-31 | $1.79 |
| 2021-12-31 | $1.06 |
| 2021-09-30 | $1.21 |
| 2021-06-30 | $2.11 |
| 2021-03-31 | $1.69 |
| 2020-12-31 | $0.74 |
| 2020-09-30 | $0.93 |
| 2020-06-30 | $2.27 |
| 2020-03-31 | $1.54 |
| 2019-12-31 | $1.35 |
| 2019-09-30 | $1.17 |
| 2019-06-30 | $1.49 |
| 2019-03-31 | $1.09 |
| 2018-12-31 | $-0.39 |
| 2018-09-30 | $1.36 |
| 2018-06-30 | $-2.52 |
| 2018-03-31 | $0.98 |
| 2017-12-31 | $3.22 |
| 2017-09-30 | $1.26 |
| 2017-06-30 | $1.07 |
| 2017-03-31 | $0.92 |
| 2016-12-31 | $1.59 |
| 2016-09-30 | $1.44 |
| 2016-06-30 | $0.86 |
| 2016-03-31 | $1.04 |
| 2015-12-31 | $1.34 |
| 2015-09-30 | $1.11 |
| 2015-06-30 | $1.13 |
| 2015-03-31 | $1.08 |
| 2014-12-31 | $1.13 |
| 2014-09-30 | $0.82 |
| 2014-06-30 | $1.07 |
| 2014-03-31 | $0.96 |
| 2013-12-31 | $1.05 |
| 2013-09-30 | $1.03 |
| 2013-06-30 | $0.92 |
| 2013-03-31 | $0.77 |
| 2012-12-31 | $0.88 |
| 2012-09-30 | $0.80 |
| 2012-06-30 | $0.76 |
| 2012-03-31 | $0.60 |
| 2011-12-31 | $0.82 |
| 2011-09-30 | $0.65 |
| 2011-06-30 | $0.60 |
| 2011-03-31 | $0.52 |
| 2010-12-31 | $0.76 |
| 2010-09-30 | $0.59 |
| 2010-06-30 | $0.60 |
| 2010-03-31 | $0.56 |
| 2009-12-31 | $0.75 |
| 2009-09-30 | $0.71 |
| 2009-06-30 | $0.61 |
| 2009-03-31 | $0.51 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $83.583B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.755B | 27.77 |
| Elevance Health (ELV) | United States | $66.299B | 8.92 |
| Cencora (COR) | United States | $56.410B | 18.79 |
| DiDi Global (DIDIY) | China | $26.262B | 27.90 |
| Labcorp Holdings (LH) | United States | $22.648B | 18.00 |
| Natera (NTRA) | United States | $21.644B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.857B | 0.00 |
| ICON (ICLR) | Ireland | $14.237B | 13.70 |
| CochLear (CHEOY) | Australia | $13.302B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.148B | 34.80 |
| Solventum (SOLV) | United States | $12.897B | 13.31 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Revvity (RVTY) | United States | $10.554B | 18.59 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.640B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.130B | 0.00 |
| Avantor (AVTR) | United States | $8.910B | 13.07 |
| HealthEquity (HQY) | United States | $7.720B | 33.81 |
| Charles River Laboratories (CRL) | United States | $7.628B | 14.47 |
| Bausch + Lomb (BLCO) | Canada | $5.016B | 33.74 |
| Sotera Health (SHC) | United States | $4.465B | 24.95 |
| BrightSpring Health Services (BTSG) | United States | $3.966B | 30.26 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.536B | 80.99 |
| Surgery Partners (SGRY) | United States | $3.021B | 38.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Alignment Healthcare (ALHC) | United States | $2.923B | 0.00 |
| Organon (OGN) | United States | $2.433B | 2.65 |
| Premier (PINC) | United States | $2.020B | 15.33 |
| Progyny (PGNY) | United States | $1.983B | 41.93 |
| Ardent Health (ARDT) | United States | $1.813B | 7.00 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.350B | 9.01 |
| Teladoc Health (TDOC) | United States | $1.315B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.272B | 20.94 |
| Establishment Labs Holdings (ESTA) | $1.111B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.815B | 4.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.714B | 8.83 |
| CareDx (CDNA) | United States | $0.646B | 11.89 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.584B | 8.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| So-Young (SY) | China | $0.517B | 0.00 |
| Omada Health (OMDA) | $0.517B | 0.00 | |
| InnovAge Holding (INNV) | United States | $0.494B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
| SBC Medicals (SBC) | United States | $0.447B | 9.81 |
| Agilon Health (AGL) | United States | $0.435B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.384B | 25.23 |
| Oncology Institute (TOI) | United States | $0.366B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| Beauty Health (SKIN) | United States | $0.300B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.132B | 0.00 |
| KindlyMD (NAKA) | United States | $0.101B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.056B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |